면역 건강 및 질병저항성 FMCG 시장 예측(-2032년) 제품별, 영양소 유형별, 형태별, 유통 채널별, 용도별, 최종사용자별, 지역별

According to Stratistics MRC, the Global Immune Health & Disease Resistance FMCG Market is accounted for $49.29 billion in 2025 and is expected to reach $77.61 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Immune Health & Disease Resistance FMCG refers to fast-moving consumer goods formulated to support, strengthen, and maintain the body's natural immune defenses while reducing susceptibility to common illnesses. This category includes foods, beverages, supplements, and daily-use products enriched with vitamins, minerals, probiotics, botanicals, and functional ingredients that enhance immunity. These products are designed for regular consumption, preventive health management, and overall wellness, catering to consumers seeking convenient, accessible solutions to improve resilience against infections and lifestyle-related health challenges.

Market Dynamics:

Driver:

Expansion of the gut-immune axis

Research highlighting the role of probiotics, prebiotics, and postbiotics in strengthening immune responses is influencing consumer purchasing behavior. Food and beverage manufacturers are increasingly formulating products that support microbiome balance to enhance immunity. Rising awareness of digestive health as a foundation for disease prevention is accelerating innovation in functional foods and beverages. Advancements in microbiome research are enabling more targeted ingredient development. Consumers are actively seeking products that offer holistic immune support rather than symptom-based solutions. This paradigm shift is reinforcing long-term growth across immune-focused FMCG categories.

Restraint:

Regulatory complexity & health claims

Authorities enforce strict guidelines on ingredient validation, labeling, and substantiation of immunity-related benefits. Manufacturers must navigate varying regulations across regions, increasing compliance costs and time-to-market. Claims linked to disease prevention or immune enhancement often requires extensive clinical evidence. Smaller FMCG brands face difficulties meeting documentation and testing requirements. Frequent updates to food safety and nutraceutical regulations further complicate product approvals. These regulatory hurdles slow innovation and limit aggressive marketing strategies.

Opportunity:

AI-driven personalized nutrition

AI-powered platforms analyze consumer data, lifestyle factors, and health metrics to recommend tailored immune-support products. Companies are leveraging digital tools to customize formulations based on age, stress levels, and dietary habits. Personalized immune solutions are gaining traction among health-conscious consumers seeking targeted benefits. Advances in wearable technology and health apps are strengthening data-driven nutrition ecosystems. FMCG players are partnering with health-tech firms to enhance personalization capabilities. This convergence of AI and nutrition is reshaping product differentiation and consumer engagement.

Threat:

The counterfeit & adulteration crisis

The increasing prevalence of counterfeit and adulterated immune health products poses a serious threat to market credibility. Unauthorized products often contain substandard or harmful ingredients, eroding consumer trust. Weak supply chain oversight in certain regions enables counterfeit goods to penetrate retail and online channels. Regulatory bodies are intensifying surveillance, but enforcement remains inconsistent across markets. Brands face reputational damage and financial losses due to counterfeit proliferation. Advanced traceability technologies are being adopted, though implementation costs remain high.

Covid-19 Impact:

The COVID-19 pandemic significantly reshaped the immune health and disease resistance FMCG market. Consumer focus shifted sharply toward preventive health, immunity-boosting foods, and functional beverages. Demand surged for products containing vitamins, minerals, botanicals, and probiotics. Supply chain disruptions initially affected ingredient sourcing and manufacturing continuity. However, digital commerce and direct-to-consumer channels expanded rapidly during lockdowns. Brands accelerated innovation cycles to meet heightened immunity awareness. Post-pandemic, immune health has transitioned from a reactive to a daily wellness priority.

The functional beverages segment is expected to be the largest during the forecast period

The functional beverages segment is expected to account for the largest market share during the forecast period. These products offer convenient and fast-absorbing immune support through fortified drinks. Growing consumption of vitamin-enriched waters, kombucha, and immunity shots is fueling segment expansion. Beverage formats appeal strongly to younger demographics and urban consumers. Manufacturers are innovating with natural ingredients, reduced sugar, and clean-label formulations. Increased on-the-go lifestyles further support beverage adoption.

The cognitive stress resilience support segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive stress resilience support segment is predicted to witness the highest growth rate. Rising awareness of the link between stress, immunity, and mental health is driving demand. Consumers are seeking products that combine immune defense with mood and cognitive support. Ingredients such as adaptogens, nootropics, and functional botanicals are gaining popularity. Increasing workplace stress and digital fatigue are influencing purchasing decisions. Brands are positioning stress-immunity solutions as part of daily wellness routines.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. High consumer awareness regarding preventive healthcare supports strong product adoption. The region benefits from advanced retail infrastructure and high penetration of functional foods. Major FMCG companies continuously invest in immune-focused product innovation. Regulatory clarity around dietary supplements enhances market stability. Strong purchasing power enables premium product consumption.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanization and rising disposable incomes are driving immune health product consumption. Traditional medicine systems combined with modern FMCG formats are gaining traction. Increasing health awareness following pandemic experiences is accelerating demand. Expanding middle-class populations are adopting functional foods and beverages. E-commerce growth is improving product accessibility across the region.

Key players in the market

Some of the key players in Immune Health & Disease Resistance FMCG Market include Nestle S.A., Danone S.A., Amway Corporation, Herbalife Nutrition Ltd., Abbott Laboratories, Bayer AG, Pfizer Inc., GlaxoSmithKline plc (GSK), Unilever plc, PepsiCo, Inc., Blackmores Limited, Nature's Bounty Co., NOW Foods, Yakult Honsha Co., Ltd., and Hain Celestial Group, Inc.

Key Developments:

In December 2025, Nestle's iconic Maggi brand has teamed up with Ninja, to deliver innovative air fryer solutions to consumers in the Middle East and North Africa (MENA). Building on the rising popularity of these novel kitchen appliances in the region, this collaboration aims to inspire wholesome, more convenient, delicious home cooking.

In September 2025, Davenport University and Amway sign partnership to spur talent development. Leaders from Davenport University and Amway formalized their commitment to higher education and talent development with a signing ceremony held at the Amway headquarters in Ada, located a few miles east of the city of Grand Rapids. The agreement, signed September 29, 2025, provides scholarship opportunities for employees of Amway and their family members.

Products Covered:

• Functional Beverages
• Functional Foods
• Fortified Dairy & Alternatives
• Bakery & Confectionery with Immunity Claims
• Nutraceutical-Infused FMCG Products
• Sports & Performance Nutrition Products
• Immune Shots & Concentrates
• Other Products

Nutrient Types Covered:

• Vitamins
• Minerals
• Probiotics & Prebiotics
• Herbal & Botanical Extracts
• Omega-3 & Fatty Acids
• Other Nutrient TypeS

Forms Covered:

• Liquids & Drinks
• Powder Mixes
• Tablets & Capsules
• Gummies & Chewables
• Bars & Snack Formats

Distribution Channels Covered:

• Supermarkets & Hypermarkets
• Pharmacy & Drug Retail
• Convenience & Specialty Stores
• Online / E-Commerce Retail
• Direct Selling & MLM Channels
• Modern Trade vs Traditional Trade

Applications Covered:

• General Immune Support
• Seasonal Wellness Support
• Gut & Digestive Immune Interaction
• Post-Illness Recovery
• Energy + Immune Support
• Cognitive Stress Resilience Support
• Other Applications

End Users Covered:

• Adults
• Children & Teens
• Elderly
• Gender-Based
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Immune Health & Disease Resistance FMCG Market, By Product

• 5.1 Introduction
• 5.2 Functional Beverages
• 5.3 Functional Foods
• 5.4 Fortified Dairy & Alternatives
• 5.5 Bakery & Confectionery with Immunity Claims
• 5.6 Nutraceutical-Infused FMCG Products
• 5.7 Sports & Performance Nutrition Products
• 5.8 Immune Shots & Concentrates
• 5.9 Other Products

6 Global Immune Health & Disease Resistance FMCG Market, By Nutrient Type

• 6.1 Introduction
• 6.2 Vitamins
• 6.3 Minerals
• 6.4 Probiotics & Prebiotics
• 6.5 Herbal & Botanical Extracts
• 6.6 Omega-3 & Fatty Acids
• 6.7 Other Nutrient TypeS

7 Global Immune Health & Disease Resistance FMCG Market, By Form

• 7.1 Introduction
• 7.2 Liquids & Drinks
• 7.3 Powder Mixes
• 7.4 Tablets & Capsules
• 7.5 Gummies & Chewables
• 7.6 Bars & Snack Formats

8 Global Immune Health & Disease Resistance FMCG Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Supermarkets & Hypermarkets
• 8.3 Pharmacy & Drug Retail
• 8.4 Convenience & Specialty Stores
• 8.5 Online / E-Commerce Retail
• 8.6 Direct Selling & MLM Channels
• 8.7 Modern Trade vs Traditional Trade

9 Global Immune Health & Disease Resistance FMCG Market, By Application

• 9.1 Introduction
• 9.2 General Immune Support
• 9.3 Seasonal Wellness Support
• 9.4 Gut & Digestive Immune Interaction
• 9.5 Post-Illness Recovery
• 9.6 Energy + Immune Support
• 9.7 Cognitive Stress Resilience Support
• 9.8 Other Applications

10 Global Immune Health & Disease Resistance FMCG Market, By End User

• 10.1 Introduction
• 10.2 Adults
• 10.3 Children & Teens
• 10.4 Elderly
• 10.5 Gender-Based
• 10.6 Other End Users

11 Global Immune Health & Disease Resistance FMCG Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Nestle S.A.
• 13.2 Danone S.A.
• 13.3 Amway Corporation
• 13.4 Herbalife Nutrition Ltd.
• 13.5 Abbott Laboratories
• 13.6 Bayer AG
• 13.7 Pfizer Inc.
• 13.8 GlaxoSmithKline plc (GSK)
• 13.9 Unilever plc
• 13.10 PepsiCo, Inc.
• 13.11 Blackmores Limited
• 13.12 Nature's Bounty Co.
• 13.13 NOW Foods
• 13.14 Yakult Honsha Co., Ltd.
• 13.15 Hain Celestial Group, Inc.